Literature DB >> 26459371

Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease.

Claudio Luchini1, Pietro Parcesepe2, Andrea Mafficini3, Alessia Nottegar2, Claudia Parolini2, Nicola Veronese4, Andrea Remo5, Erminia Manfrin2.   

Abstract

INTRODUCTION: The epithelial to mesenchymal transition, a well-known and re-emerging model in pathology, has not been completely investigated in the field of gestational pathology. This study aims at improving the comprehension of this process in molar disease, even looking for new possible immunohistochemical markers.
MATERIALS AND METHODS: We have analysed the immunohistochemical expression of Twist1 and Snai2, two of the most important transcription factors involved in epithelial to mesenchymal transition, in formalin-fixed paraffin-embedded samples of 23 spontaneous abortive pregnancies, 22 molar pregnancies (10 partial and 12 complete) and 7 term placentas.
RESULTS: Twist1 and Snai2 were highly expressed in stromal villi cells of molar disease. Particularly, Twist1 was highly expressed in complete moles compared to both abortive pregnancies (p < 0.001) and partial moles (p < 0.05). Also Snai2 was more expressed by complete moles, differentiating them from non-molar abortions (p < 0.05). DISCUSSION: On the basis of the known cadherins and claudins expression in these pathologies, our new findings reinforce the hypothesis of the involvement of epithelial to mesenchymal transition in early molar pregnancies and above all in complete moles. Furthermore, we highlighted that in molar disease not only the trophoblast, but even the villi stromal cells, are involved. Thanks to their specificity, furthermore, these Twist1 and Snai2 could be used as additional immunohistochemical tool in the diagnosis of complete molar disease, with Twist1 as the first choice.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complete mole; EMT; Molar disease; Snai2; Twist; Twist1

Mesh:

Substances:

Year:  2015        PMID: 26459371     DOI: 10.1016/j.placenta.2015.09.012

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  6 in total

1.  Epithelial-mesenchymal transition during extravillous trophoblast differentiation.

Authors:  Jessica E Davies; Jürgen Pollheimer; Hannah E J Yong; Maria I Kokkinos; Bill Kalionis; Martin Knöfler; Padma Murthi
Journal:  Cell Adh Migr       Date:  2016-04-12       Impact factor: 3.405

2.  Gestational trophoblastic neoplasms (GTNs) do not display epithelial-to-mesenchymal transition (EMT) features.

Authors:  Estelle Dubruc; Fabienne Allias; Anne Pierre Morel; François Golfier; Alain Puisieux; Mojgan Devouassoux-Shisheboran
Journal:  Virchows Arch       Date:  2019-03-08       Impact factor: 4.064

3.  Fhit down-regulation is an early event in pancreatic carcinogenesis.

Authors:  Matteo Fassan; Borislav Rusev; Vincenzo Corbo; Pierluigi Gasparini; Claudio Luchini; Caterina Vicentini; Andrea Mafficini; Salvatore Paiella; Roberto Salvia; Ivana Cataldo; Aldo Scarpa; Kay Huebner
Journal:  Virchows Arch       Date:  2017-03-13       Impact factor: 4.064

4.  A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature.

Authors:  Giulia De Marchi; Salvatore Paiella; Claudio Luchini; Antonio Amodio; Borislav Rusev; Claudio Bassi; Riccardo Manfredi; Luca Frulloni
Journal:  J Gastrointest Oncol       Date:  2016-06

5.  RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes.

Authors:  Eliana Amato; Stefano Barbi; Matteo Fassan; Claudio Luchini; Caterina Vicentini; Matteo Brunelli; Giuseppe Malleo; Aldo Scarpa; Giorgio Malpeli
Journal:  BMC Cancer       Date:  2016-01-12       Impact factor: 4.430

6.  CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype.

Authors:  Paola Mattiolo; Seung-Mo Hong; Gaetano Paolino; Borislav C Rusev; Giovanni Marchegiani; Roberto Salvia; Stefano Andrianello; Paola Capelli; Paola Piccoli; Claudia Parolini; Aldo Scarpa; Rita T Lawlor; Claudio Luchini
Journal:  Int J Mol Sci       Date:  2020-08-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.